Aadel Chaudhuri, MD, PhD, is a physician-scientist and Assistant Professor of Radiation Oncology, Genetics, Biomedical Engineering, and Computer Science at the Washington University in St. Louis. He is also the ctDNA working group leader at the Washington University Siteman Cancer Center. He additionally serves as Co-Chair of the Liquid Biopsies Working Group within the National Institutes of Health. 

Dr. Chaudhuri completed his MD at Stanford, PhD at Caltech, and BS degrees in Biology and Computer Science at MIT. He completed his PhD in Biology under the mentorship of Dr. David Baltimore focusing on microRNAs in cancer, and his residency at Stanford University, where he did postdoctoral work with Dr. Maximilian Diehn demonstrating that circulating tumor DNA (ctDNA) serves as a powerful biomarker for molecular residual disease (MRD) after curative-intent localized lung cancer treatment. Dr. Chaudhuri’s laboratory at Washington University is a translational genomics lab that focuses on the development and application of liquid biopsy cancer diagnostic technologies with the goal of more precisely personalizing solid tumor malignancy treatment. His laboratory is funded by the National Institutes of Health, the V Foundation, the Children’s Discovery Institute, the Children’s Tumor Foundation, the Alvin Siteman Cancer Research Fund, and the Melanoma Research Alliance.